• About
    • Team
    • Contact
  • Ophthalmics
  • Investors
    • AGM Notices
    • Financials
    • Research & Development
  • News


Home
/
News
/
Page 2

Genix Announces Change of Auditor

November 14, 2022
Vancouver, British Columbia, November 10, 2022 – Genix Pharmaceuticals Corporation…

Genix Announces Auditor Resignation

November 14, 2022
Vancouver, British Columbia, September 6, 2022 – Genix Pharmaceuticals Corporation…

Genix Receives Approval to Extend Warrants from the TSX Venture Exchange

July 28, 2022
Vancouver, British Columbia, July 28, 2022 – Genix Pharmaceuticals Corporation (TSX-V: GENX; OTCQB: GENPF)…

Genix Proposes to Extend Warrants

July 20, 2022
Vancouver, British Columbia, July 20, 2022 – Genix Pharmaceuticals Corporation…

Genix Pharmaceuticals Corporation Receives Natural Product Number for Rechlor from Health Canada

September 8, 2021
Vancouver, British Columbia, September 08, 2021 – Genix Pharmaceuticals Corporation (TSX-V: GENX; OTCQB: GENPF)…

Genix Pharmaceuticals Corp. Receives Approval for Drug Establishment License

July 15, 2021
Vancouver, British Columbia, July 15th, 2021 – Genix Pharmaceuticals Corporation (TSX-V:…
Previous 1 2 3 4 5 Next
Suite 300, 1055 West Hastings St, Vancouver, BC, V6E 2E9
604.609.6198
info@genixpharm.com

LINKS

  • Ophthalmics
  • Investors
  • News

OUR COMPANY

  • About
  • Investors
  • Contact
  • Disclaimers
  • Terms of service

OUR NEWSLETTER

Subscribe to the mailing list to receive updates on new arrivals, special offers and other information


© 2022 Created by Genix Pharmaceuticals